Profile data is unavailable for this security.
About the company
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
- Revenue in USD (TTM)46.58m
- Net income in USD15.63m
- Incorporated1978
- Employees169.00
- LocationUtah Medical Products Inc7043 S 300 WestMIDVALE 84047United StatesUSA
- Phone+1 (801) 566-1200
- Fax+1 (801) 566-7305
- Websitehttp://www.utahmed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accuray Inc | 446.55m | -15.55m | 173.46m | 1.02k | -- | 3.81 | -- | 0.3885 | -0.1596 | -0.1596 | 4.53 | 0.4543 | 0.9423 | 2.14 | 5.36 | -- | -3.28 | -1.37 | -5.61 | -2.33 | 32.05 | 36.42 | -3.48 | -1.55 | 0.947 | 0.3757 | 0.7925 | -- | -0.2355 | 1.29 | -67.51 | -- | -- | -- |
| Electromed Inc | 54.72m | 5.15m | 175.28m | 174.00 | 35.04 | 3.93 | 29.26 | 3.20 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
| Stereotaxis Inc | 23.75m | -22.08m | 178.62m | 122.00 | -- | 15.42 | -- | 7.52 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 186.48m | 56.00 | -- | 4.00 | -- | 89.69 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Trubridge Inc | 336.56m | -52.28m | 187.75m | 3.22k | -- | 1.04 | -- | 0.5579 | -3.68 | -3.68 | 23.64 | 12.12 | 0.7947 | 196.76 | 5.88 | 104,553.30 | -12.66 | 1.25 | -14.34 | 1.41 | 48.70 | 50.40 | -15.93 | 1.56 | 1.76 | 0.6115 | 0.4985 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
| Senseonics Holdings Inc | 24.04m | -80.46m | 192.86m | 132.00 | -- | 333.48 | -- | 8.02 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| CVRx Inc | 44.39m | -54.39m | 198.47m | 200.00 | -- | 3.58 | -- | 4.47 | -2.57 | -2.57 | 2.10 | 2.54 | 0.4209 | 0.6253 | 5.79 | 221,965.00 | -51.56 | -- | -56.39 | -- | 84.40 | -- | -122.52 | -- | 8.85 | -18.48 | 0.3467 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| LifeMD Inc | 178.28m | -26.60m | 211.47m | 207.00 | -- | -- | -- | 1.19 | -0.7004 | -0.7004 | 4.70 | -0.101 | 3.59 | 6.86 | 38.19 | 861,255.40 | -44.31 | -153.05 | -333.96 | -526.91 | 88.92 | 83.66 | -12.34 | -45.44 | 0.8327 | -8.19 | 1.13 | -- | 28.15 | 78.90 | 51.27 | -- | 143.64 | -- |
| Neuropace Inc | 71.82m | -29.90m | 217.81m | 171.00 | -- | 21.99 | -- | 3.03 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| Nevro Corp | 426.10m | -77.44m | 218.11m | 1.22k | -- | 0.7936 | -- | 0.5119 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Utah Medical Products, Inc. | 46.58m | 15.63m | 230.57m | 169.00 | 15.31 | 1.87 | 11.66 | 4.95 | 4.33 | 4.33 | 12.92 | 35.45 | 0.3576 | 1.99 | 12.81 | 275,609.50 | 12.00 | 12.69 | 12.43 | 13.19 | 58.99 | 61.57 | 33.56 | 30.51 | 23.68 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| Inogen Inc | 326.65m | -92.44m | 248.34m | 834.00 | -- | 1.32 | -- | 0.7603 | -3.97 | -3.97 | 13.97 | 7.91 | 0.9562 | 6.85 | 7.49 | 391,670.30 | -27.06 | -8.23 | -33.51 | -9.53 | 42.56 | 44.54 | -28.30 | -10.31 | 2.37 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Delcath Systems Inc | 11.88m | -56.33m | 252.00m | 76.00 | -- | 59.97 | -- | 21.22 | -2.55 | -2.55 | 0.505 | 0.1501 | 0.4322 | 0.6198 | 6.17 | 156,289.50 | -204.97 | -116.57 | -356.98 | -243.21 | 77.05 | 71.02 | -474.22 | -1,235.37 | 2.04 | -54.37 | 0.5172 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Zynex Inc | 193.61m | 6.04m | 257.75m | 1.10k | 46.83 | 7.99 | 24.36 | 1.33 | 0.1734 | 0.1734 | 5.73 | 1.02 | 1.41 | 2.56 | 6.85 | 176,012.70 | 4.40 | 14.58 | 4.99 | 17.52 | 80.36 | 79.62 | 3.12 | 10.44 | 3.22 | 5.74 | 0.642 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Alpha Teknova Inc | 34.94m | -34.27m | 271.85m | 210.00 | -- | 2.64 | -- | 7.78 | -0.9295 | -0.9295 | 0.9167 | 1.93 | 0.2819 | 2.36 | 6.84 | 166,381.00 | -27.65 | -- | -32.36 | -- | 22.38 | -- | -98.08 | -- | 3.28 | -29.50 | 0.144 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| Atlantic International Corp | 205.26m | -62.29m | 297.25m | 7.00 | -- | 11.68 | -- | 1.45 | -8.72 | -8.72 | 14.59 | 0.5222 | 2.91 | -- | 7.03 | 29,322,780.00 | -88.44 | -71.97 | -174.30 | -106.09 | 10.70 | 61.01 | -30.35 | -1,471.82 | -- | -1.33 | 0.7735 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD
43.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 385.39k | 10.92% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 227.11k | 6.44% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 182.10k | 5.16% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 176.69k | 5.01% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 162.47k | 4.60% |
| Geode Capital Management LLCas of 30 Jun 2024 | 88.56k | 2.51% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 80.66k | 2.29% |
| Ranger Investment Management LPas of 31 Mar 2024 | 80.45k | 2.28% |
| Brandes Investment Partners LPas of 31 Mar 2024 | 70.10k | 1.99% |
| Rice, Hall, James & Associates LLCas of 30 Jun 2024 | 67.04k | 1.90% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
